Fungal endophthalmitis is a severe and sight-threatening condition characterized by the inflammation of the internal ocular structures due to fungal infection. It can arise through various routes, such as post-surgical complications, trauma, or hematogenous spread from systemic fungal infections. Candida species, particularly Candida albicans, are common culprits, but Aspergillus and Fusarium species can also cause fungal endophthalmitis. Patients with fungal endophthalmitis typically present with symptoms such as sudden vision loss, pain, redness, and increased sensitivity to light. The infection can progress rapidly, leading to irreversible damage if not promptly diagnosed and treated. Diagnosis involves clinical examination, imaging studies, and laboratory analysis of intraocular fluids. Early intervention with antifungal medications and, in severe cases, surgical intervention is crucial for preserving vision and preventing further complications. Preventive measures include maintaining sterile conditions during ocular surgeries, prompt management of systemic fungal infections, and vigilance in immunocompromised individuals. Fungal endophthalmitis remains a challenging condition, requiring a multidisciplinary approach involving ophthalmologists, infectious disease specialists, and microbiologists.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation